304 related articles for article (PubMed ID: 22872171)
41. A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review.
Van Skike CE; Galvan V
Gerontology; 2018; 64(3):205-211. PubMed ID: 29320772
[TBL] [Abstract][Full Text] [Related]
42. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
de la Torre JC
Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
[TBL] [Abstract][Full Text] [Related]
43. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases.
Farkas E; Luiten PG; Bari F
Brain Res Rev; 2007 Apr; 54(1):162-80. PubMed ID: 17296232
[TBL] [Abstract][Full Text] [Related]
44. Lixisenatide, a novel GLP-1 analog, protects against cerebral ischemia/reperfusion injury in diabetic rats.
Abdel-Latif RG; Heeba GH; Taye A; Khalifa MMA
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jul; 391(7):705-717. PubMed ID: 29671019
[TBL] [Abstract][Full Text] [Related]
45. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH
Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785
[TBL] [Abstract][Full Text] [Related]
46. Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS.
Wang Q; Sun AY; Simonyi A; Kalogeris TJ; Miller DK; Sun GY; Korthuis RJ
Free Radic Biol Med; 2007 Oct; 43(7):1048-60. PubMed ID: 17761301
[TBL] [Abstract][Full Text] [Related]
47. Astrocyte-produced carbon monoxide and the carbon monoxide donor CORM-A1 protect against cerebrovascular dysfunction caused by prolonged neonatal asphyxia.
Parfenova H; Pourcyrous M; Fedinec AL; Liu J; Basuroy S; Leffler CW
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H978-H988. PubMed ID: 30028198
[TBL] [Abstract][Full Text] [Related]
48. Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1.
Papadopoulos P; Tong XK; Imboden H; Hamel E
J Cereb Blood Flow Metab; 2017 Jun; 37(6):1959-1970. PubMed ID: 27389178
[TBL] [Abstract][Full Text] [Related]
49. NADPH Oxidase Inhibition: Preclinical and Clinical Studies in Diabetic Complications.
Urner S; Ho F; Jha JC; Ziegler D; Jandeleit-Dahm K
Antioxid Redox Signal; 2020 Aug; 33(6):415-434. PubMed ID: 32008354
[No Abstract] [Full Text] [Related]
50. Molecular Mechanisms of Vascular Dementia: What Can Be Learned from Animal Models of Chronic Cerebral Hypoperfusion?
Du SQ; Wang XR; Xiao LY; Tu JF; Zhu W; He T; Liu CZ
Mol Neurobiol; 2017 Jul; 54(5):3670-3682. PubMed ID: 27206432
[TBL] [Abstract][Full Text] [Related]
51. Protective effects of Chrysin against memory impairment, cerebral hyperemia and oxidative stress after cerebral hypoperfusion and reperfusion in rats.
Shooshtari MK; Sarkaki A; Mansouri SMT; Badavi M; Khorsandi L; Ghasemi Dehcheshmeh M; Farbood Y
Metab Brain Dis; 2020 Feb; 35(2):401-412. PubMed ID: 31853830
[TBL] [Abstract][Full Text] [Related]
52. Diagnosis and management of vascular cognitive impairment and dementia.
Erkinjuntti T
J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
[TBL] [Abstract][Full Text] [Related]
53. [The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].
Horváth S
Orv Hetil; 2001 Feb; 142(8):383-9. PubMed ID: 11263076
[TBL] [Abstract][Full Text] [Related]
54. Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.
Tarantini S; Tran CHT; Gordon GR; Ungvari Z; Csiszar A
Exp Gerontol; 2017 Aug; 94():52-58. PubMed ID: 27845201
[TBL] [Abstract][Full Text] [Related]
55. Sleep fragmentation induces cognitive deficits via nicotinamide adenine dinucleotide phosphate oxidase-dependent pathways in mouse.
Nair D; Zhang SX; Ramesh V; Hakim F; Kaushal N; Wang Y; Gozal D
Am J Respir Crit Care Med; 2011 Dec; 184(11):1305-12. PubMed ID: 21868506
[TBL] [Abstract][Full Text] [Related]
56. Threats to the mind: aging, amyloid, and hypertension.
Iadecola C; Park L; Capone C
Stroke; 2009 Mar; 40(3 Suppl):S40-4. PubMed ID: 19064785
[TBL] [Abstract][Full Text] [Related]
57. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
Wang X; Hu X; Yang Y; Takata T; Sakurai T
Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
[TBL] [Abstract][Full Text] [Related]
58. From neuronal and vascular impairment to dementia.
De Deyn PP; Goeman J; Engelborghs S; Hauben U; D'Hooge R; Baro F; Pickut BA
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():17-24. PubMed ID: 10338104
[TBL] [Abstract][Full Text] [Related]
59. Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
Hamel E; Nicolakakis N; Aboulkassim T; Ongali B; Tong XK
Exp Physiol; 2008 Jan; 93(1):116-20. PubMed ID: 17911359
[TBL] [Abstract][Full Text] [Related]
60. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease.
Kalaria RN
Neurobiol Aging; 2009 Sep; 30(9):1512-4. PubMed ID: 18187235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
